Start Date: ,
End Date: ,
Click here to access the article.
Highlights
- A total of 7 studies evaluated outcomes of Impella versus IABP in patients with cardiogenic shock on venoarterial extracorporeal membrane oxygenation.
- The use of Impella and IABP in patients on venoarterial extracorporeal membrane oxygenation has comparable effects on short-term mortality.
- However, Impella use was associated with a significantly higher risk of major bleeding and hemolysis.
- No significant differences were observed in left ventricular assist devices transition, continuous renal replacement therapy initiation, or stroke.
- In patients with cardiogenic shock, IABP may be as effective as Impella in LV unloading.